Coya Therapeutics
NASDAQ: COYAHouston, US · Founded 2020 · Delaware corporation · 1 known investors
Founders & leadership
DS
David SnyderinExecutive
FG
Fred GrossmanExecutive
HB
Howard BermanExecutive
AG
Andrea GoldsteinNamed on SEC filing
JT
Jani TuomiNamed on SEC filing
SM
Shawn M. TitcombNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$56.9M disclosed across 4 of 7 rounds · 2020–2026
▶$10MraisedOct 2024 · 9 investors · BiotechnologyRule 506(b)
▶$10MraisedOct 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SnyderExecutive Officer
- Hideki GarrenDirector
- Anabella VillalobosDirector
- Dieter WeinandDirector
- Ann LeeDirector
- Fred GrossmanExecutive Officer
- Dov GoldsteinDirector
- Wilbur RossDirector
- Howard BermanExecutive Officer, Director
- Arun SwaminathanDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Sales commissions
- $700K
- Placement agents
- Wilmington Capital Securities, LLC, Chardan Capital Markets LLC, BTIG, LLC
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$26.5MraisedDec 2023 · 122 investors · BiotechnologyRule 506(b)
▶$26.5MraisedDec 2023 · 122 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dieter WeinandDirector
- Ann LeeDirector
- Wilbur RossDirector
- Fred GrossmanExecutive Officer
- Howard BermanExecutive Officer, Director
- Hideki GarrenDirector
- Dov GoldsteinDirector
- Anabella VillalobosDirector
- David SnyderExecutive Officer
- Offering amount
- $26.5M
- Amount sold
- $26.5M
- Placement agents
- BTIG, LLC, Newbridge Securities Corporation
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$10.4MraisedMay 2022 · 45 investors · BiotechnologyRule 506(b)
▶$10.4MraisedMay 2022 · 45 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SnyderExecutive Officer
- Anabella VillalobosDirector
- Dov GoldsteinDirector
- Adrian HepnerExecutive Officer
- Ann LeeDirector
- Howard BermanExecutive Officer, Director
- Hideki GarrenDirector
- Greg MacMichaelExecutive Officer
- Offering amount
- $20M
- Amount sold
- $10.4M
- Sales commissions
- $1.4M
- Placement agents
- Wilmington Capital Securities, LLC
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$10MraisedJan 2021 · 57 investors · BiotechnologyRule 506(b)
▶$10MraisedJan 2021 · 57 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard BermanExecutive Officer, Director
- Andrea GoldsteinExecutive Officer, Director
- Jani TuomiDirector
- Shawn M. TitcombDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Sales commissions
- $700K
- Placement agents
- Shawn M. Titcomb
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapBioworld74 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Kite Pharma62 shared keywordsKite Pharma develops CAR T-cell therapies for cancer patients, engineering the immune system's cells to target and attack cancer. Each therapy is individualized per patient through a multi-step manufacturing process.
Companies competing with Coya Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who are Coya Therapeutics's investors?
- Coya Therapeutics's investors include Checkmate Capital Group LLC.
- How much funding has Coya Therapeutics raised?
- Coya Therapeutics has disclosed $56.9M raised across 4 of its 7 known rounds.
- Where is Coya Therapeutics headquartered?
- Coya Therapeutics is headquartered in Houston, US.